New York, April 17, 2015 -- Moody's Investors Service commented that the announcement that Aurora Diagnostics Holdings, LLC had amended and restated its credit agreement is modestly credit positive as it improves the company's ability to pursue acquisitions of additional pathology practices that could reduce leverage. However, there is no change to the company's ratings, including Aurora's Caa2 Corporate Family Rating and Caa2-PD Probability of Default Rating. The stable rating outlook is also unchanged.

Vollständigen Artikel bei Moodys lesen